Evidence map›Paper›PMID 16808148›Full record

ArticleLipids2006

Effect of diacylglycerol on the development of impaired glucose tolerance in sucrose-fed rats.

Shinichi Meguro, Noriko Osaki, Noboru Matsuo, Ichiro Tokimitsu

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Metabolic syndrome as a risk factor for neurological disorders.Cellular and molecular life sciences : CMLS · 2012
    Review
  2. Article
  3. Review
  4. Replacements for trans fats-will there be an oil shortage?Journal of diabetes science and technology · 2007
    Article
4 · The record

Corrections and comments

  • Erratum issued
  • Erratum issued
5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shinichi MeguroBiological Science Laboratories, Kao Corporation, Tochigi, Japan. meguro.shinichi@kao.co.jp
Noriko Osaki
Noboru Matsuo
Ichiro Tokimitsu
Kao Corporation (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of DAG oil and TAG oil on impaired glucose tolerance in rats that were fed a diet containing high levels of sucrose were compared. Male Wistar rats (8 wk old and 32 wk old) were fed either high-sucrose (57.5% sucrose w/w) or control diets containing either 10% (w/w) DAG or TAG oil with a similar FA composition for 48 wk in 8-wk-old rats and for 24 wk in 32-wk-old rats. Plasma lipids, the size of the islets of Langerhans, and insulin, glucose, and adipocytokine levels were measured. An oral glucose tolerance test (OGTT) was carried out during the study period. For rats in both age groups that were fed a high-sucrose diet, the DAG oil group had lower plasma glucose and insulin response in an OGTT, and lower homeostasis model assessment-R levels, than the TAG oil group. Furthermore, in 8-wk-old rats that were fed a high-sucrose diet, the DAG oil group accumulated less visceral fat and showed suppressed decreases [corrected] of plasma adiponectin and [corrected] increases of plasma insulin, leptin, and the size of islet of Langerhans compared with the TAG oil group. No difference in the OGTT was found between the DAG and TAG oil groups in either age group of rats fed a control diet. In conclusion, these results suggest that DAG oil ingestion prevents the high-sucrose-diet-induced development of impaired glucose tolerance compared with TAG oil ingestion.

Indexed as

Abdominal FatAdipocytesAnimalsBody WeightCell SizeCytokinesDietary SucroseDiglyceridesEnergy IntakeGlucose IntoleranceGlucose Tolerance TestIslets of LangerhansLipidsLiverMaleOils1,2-diacylglycerolCytokinesDietary SucroseDiglyceridesLipidsOilsTriglycerides

Identifiers

PMID16808148
OpenAlexW2007513014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.